Sunteți pe pagina 1din 5

MARKET RESEARCH REPORTS TO DEFINE THE RIGHT STRATEGY

AND EXECUTE THROUGH TO THE SUCCESS

Polymerase Chain Reaction (PCR) A Global Market Overview


The report reviews, analyzes and projects the global market for Polymerase Chain Reaction (PCR) for the period 2014-2022.
PCR product segments analyzed in this report include Instruments, Reagents & Consumables and Software & Services.
Application Areas of PCR analyzed comprise Clinical Diagnostics, Life Sciences and Others. This study also analyzes PCR end-
use sectors including Academic & Research Institutes, Clinical Diagnostics Labs & Hospitals, Pharmaceutical & Biotechnology
and Others.

Published: October 2017


Report Code: BT026
Pages: 344
Charts: 216
Price: $4860 Single User License, $7560 Enterprise License

Report Synopsis Droplet Digital PCR Surpasses Real-Time PCR in Detecting Environmental DNA
PCR Testing for Veterinary Diseases Gaining Momentum
Polymerase chain reaction (PCR) is a technology that has opened up
Capillary Loop Convective Polymerase Chain Reaction Platform with Real-
new vistas for advances in life sciences research and molecular
Time Fluorescence Detection Improves Amplification Efficiency
diagnostics due to its attributes, such as detection and quantification
Key business trends focusing on product innovations/developments, M&As,
of DNA and RNA genetic materials. North America leads the global JVs and other recent industry developments
market for PCR, estimated at US$3.5 billion (40.3% share) in 2017,
Major companies profiled 33
which is expected to maintain a 20172022 CAGR of 7.5% in reaching
The industry guide includes the contact details for 161 companies
a projected US$5 billion by 2022.

AsiaPacific is expected to witness the fastest similar period robust Product Outline
CAGR of 9.2% and reach US$2.5 billion by 2022. Global demand for The report analyzes the market for the key product segments of PCR including:
PCR in Clinical Diagnostics Labs & Hospitals, among end use sectors, is Instruments

slated to record the fastest CAGR of 8.6% during the aforementioned Reagents & Consumables

analysis period. Software & Services


Application Areas of PCR analyzed comprise the following:
Clinical Diagnostics
Life Sciences
Others
End-Use Sectors of PCR analyzed comprise the following:
Academic & Research Institutes
Clinical Diagnostics Labs & Hospitals
Pharmaceutical & Biotechnology
Others

Analysis Period, Units and Growth Rates


The report reviews, analyzes and projects the global PCR market for the
period 2014-2022 in terms of market value in US$ and the compound annual
growth rates (CAGRs) projected from 2017 through 2022

Geographic Coverage
Research Findings & Coverage North America (The United States, Canada and Mexico)
Europe (France, Germany, Italy, The United Kingdom, and Rest of Europe)
Global PCR market is examined in this report with respect to latest prominent
technologies, major application areas and key end-use sectors Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific)
The report exclusively analyzes each application area, technology and end- Rest of World
use sector of PCR by a major geographic region

Click here to buy the report


Page 1
Polymerase Chain Reaction (PCR) A Global Market Overview
October 2017 |344 Pages | 216 Charts | Price $4860

SAMPLE COMPANY PROFILE SAMPLE TABLE/CHART


Glance at 2017 Global Polymerase Chain Reaction (PCR) Market Share (%) by
AGILENT TECHNOLOGIES, INC. (UNITED STATES) Geographic Region North America, Europe, Asia-Pacific and Rest of World
5301 Stevens Creek Blvd, Santa Clara, California 95051
Phone: 408-345-8886, Fax: 408-345-8474
Website: www.agilent.com

Business Overview
California, United States-based Agilent Technologies, Inc.,
established in 1999, is a global leader in life sciences, diagnostics
and applied markets. The company is engaged in offering products
comprising atomic absorption, automation, bioanalyzer &
tapestation (bioanalyzer DNA & RNA kits), capillary
electrophoresis & CE/MS, cell analysis (seahorse), certified pre-
owned instruments, CGH & CGH+SNP microarrays, Dako products,
dissolution, FISH probes, fluorescence, FTIR, gas chromatography,
gene expression microarrays, ICP-MS, ICP-OES, iLab operations North American Polymerase Chain Reaction (PCR) Market Analysis (2014-2022)
by Product Segment Instruments, Reagents & Consumables and Software &
software, lab supplies, liquid chromatography, mass
Services in USD Million
spectrometry, miRNA microarrays, MP-AES, Amplicon target
amplification (Multiplicom), mutagenesis & cloning, next
generation sequencing, Raman spectroscopy (cobalt light
systems), sample preparation, software & informatics, UV-Vis &
UV-Vis-NIR, and vacuum technologies for the food, environmental
and forensics, pharmaceutical, diagnostics, chemical and energy,
and life sciences and diagnostic research markets. The PCR & RT-
PCR product line offered by the company encompasses PCR
instruments & plastics, high fidelity PCR enzymes, high yield &
sensitivity, high GC, inhibited & difficult target, routine PCR & RT-
PCR, optimization, ladders & markers, PCR & RT-PCR nucleic acid
purification, polymerases & modifying enzymes, PCR-RFLP, and 2014 2017 2022
specialty kits. The qPCR portfolio includes AriaMx-qPCR
instruments & software, AriaDx-qPCR for molecular diagnostics, KEY PLAYERS PROFILED
Mx3005P & Mx3000P - qPCR instruments & software, qPCR Abbott Laboratories
plastics & accessories, Brilliant SYBR master mixes, Brilliant Abbott Molecular Inc.
probe master mixes, HRM master mix, specialty master mixes & Agilent Technologies, Inc.
kits, cDNA synthesis, qPCR reference & controls, cell lysis & Becton, Dickinson and Company
BD Biosciences, Systems and Reagents Inc.
stabilization, purified total RNA, and nucleic acid purification.
Biocartis NV
Bio-Rad Laboratories, Inc.
Product Portfolio Danaher Corporation
PCR & RT-PCR Product Particulars
Beckman Coulter, Inc.
Eppendorf AG
PCR Instruments & Plastics SureCycler 8800 thermal cycler; PCR plastics and F. Hoffmann-La Roche Ltd
accessories (plates and tubes, StrataCooler LP Roche Diagnostics Corporation
benchtop cooler, StrataCooler Cryo preservation
modules)
Fluidigm Corporation
GE Healthcare Life Sciences
High Fidelity PCR Enzymes PfuUltra II Fusion HS DNA polymerase; Herculase II Merck KGaA
Fusion DNA polymerases; PfuTurbo Cx Hotstart DNA Ocimum Biosolutions Ltd.
polymerase; Easy-A Hi-Fi cloning enzyme; AccuScript
Hi-Fi Reverse Transcriptase (RT)
Qiagen N.V.
Thermo Fisher Scientific, Inc.
High Yield & Sensitivity Herculase II Fusion DNA polymerases; Paq5000 DNA
polymerase; PicoMaxx Hi-Fi PCR system & master mix;
AffinityScript Multi-Temp RT & RT-PCR
REGION COVERAGE
North America (United States, Canada and Mexico)
High GC, Inhibited & Difficult Herculase II Fusion DNA polymerases; Pfu Turbo Cx
Target Hotstart DNA polymerase; AffinityScript Multi-Temp Europe (France, Germany, Italy, The United Kingdom and Rest of Europe)
RT & RT-PCR; SureDirect Blood PCR kit; PicoMaxx Hi-Fi Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific)
PCR systems & master mix
Rest of World
.more .more

Click here to buy the report


Page 2
Polymerase Chain Reaction (PCR) A Global Market Overview
October 2017 |344 Pages | 216 Charts | Price $4860

TABLE OF CONTENTS
PART A: GLOBAL MARKET PERSPECTIVE......... 1 2.6 PCR Testing for Veterinary Diseases Gaining Roche Introduces Cobas Liat PCR System with New Assays ... 60
Momentum.............................................................. 25 QIAGEN to Release AR-V7 Test in Prostate Cancer for
1. INTRODUCTION .................................................. 1 Research Use Only .......................................................... 60
2.7 RT-qPCR Improves Detection of Mycobacterium
1.1 Product Outline.................................................... 3 QIAGEN and CACER-ID Consortium Collaborate on Liquid
tuberculosis ............................................................. 26
1.1.1 What is Polymerase Chain Reaction (PCR)? ...... 3 Biopsies Workflows ........................................................ 61
2.8 Capillary Loop Convective Polymerase Chain QIAGEN Introduces First FDA-Cleared JAK2 Test for
1.1.1.1 Procedure of PCR ........................................... 3
Reaction Platform with Real-Time Fluorescence Leukemia Disease ........................................................... 61
1.1.1.1.1 Initialization ................................................ 4
Detection Improves Amplification Efficiency ........... 27 Roche Launches Cobas HPV on the Cobas 6800/8800
1.1.1.1.2 Denaturation............................................... 4
2.9 Droplet Digital PCR Surpasses Real-Time PCR in Systems for Cervical Cancer ............................................ 62
1.1.1.1.3 Annealing .................................................... 4 Bioline Unveils New JetSeq DNA Quantification Kits ...... 62
Detecting Environmental DNA ................................. 28
1.1.1.1.4 Extension/Elongation .................................. 4 Thermo Fisher Launches QuantStudio 5 Real-Time PCR
2.10 Nanoparticle-Assisted PCR Overcomes Technical
1.1.1.1.5 Final Elongation .......................................... 4 System for Forensic Laboratory Use ............................... 62
Challenges ............................................................... 28
1.1.1.1.6 Final Hold .................................................... 5 Digital PCR Upholds High Reproducibility International
2.11 Litmus Test Used for Detecting DNA Amplicons Multicenter Study ........................................................... 63
1.1.1.2 The Exponential Cycle of PCR ......................... 5
of PCR ...................................................................... 28 Promega and Hitachi Technologies Team-Up for Capillary
1.1.1.3 Design of Primers ........................................... 5
2.12 dPCR Used for Characterizing DNA Reference Electrophoresis (CE) Instrument ..................................... 63
1.1.1.4 Components Required for PCR ...................... 6
Materials.................................................................. 29 U.S. FDA Grants Abbott the First Commercial
1.1.1.4.1 Buffer Components ..................................... 6 Authorization for a Molecular Test to Detect Zika Virus
2.13 Innovative PCR Technique Improves Sequencing
1.1.1.4.2 Additives and Inhibitors .............................. 7 Using Whole Blood ......................................................... 64
of Minute cfDNA ...................................................... 29
1.1.1.4.3 Thermal Cycler and Thermal Cycling Global Liquid Biopsy Researchers Participate in Precision
Conditions.................................................................. 8 3. KEY GLOBAL PLAYERS ........................................ 30 Medicine World Conference on NGS & PCR Technologies ..... 64
1.1.1.5 Scrutiny of Fragment Identity ........................ 9 Abbott Laboratories (United States) ............................... 30 Bio-Rad to Acquire RainDance Technologies .................. 65
1.1.2 PCR Techniques............................................... 10 Agilent Technologies, Inc. (United States) ....................... 32 Bioline Unveils EPIK miRNA Assays .............................. 65
Becton, Dickinson and Company (United States) ............ 34 Bruker Acquires InVivo Biotech ...................................... 65
1.1.2.1 Digital PCR (dPCR) ........................................ 10
Biocartis Nv (Belgium) ..................................................... 35 QIAGEN Introduces CALR Mutation Assay for MPN
1.1.2.1.1 Principles of Digital PCR ............................ 10 Diagnosis ........................................................................ 66
Bio-Rad Laboratories, Inc. (United States)....................... 36
1.1.2.2 Real-Time PCR .............................................. 11 Danaher Corporation (United States) .............................. 37 Roche and Merck KGaA Enter into Distribution Agreement... 66
1.1.2.2.1 Principle of Real-Time PCR ........................ 11 Eppendorf Ag (Germany) ................................................ 39 Biocartis and Thermo Fisher Announce Agreement ....... 67
1.1.2.2.2 Fluorescent Dyes, Primers, and Probes Used F. Hoffmann-La Roche Ltd (Switzerland) ......................... 40 RainDance Technologies Unveils RainDrop Plus Digital PCR
in Real-Time PCR...................................................... 12 Fluidigm Corporation (United States) .............................. 42 System ............................................................................ 67
1.1.2.2.3 Applications of Real-Time PCR .................. 12 Ge Healthcare Life Sciences (United Kingdom) ............... 43 Promega Corporation Launches Promega PCR
Merck Kgaa (Germany) ................................................... 44 Optimization Kit.............................................................. 67
1.1.2.3 Other PCR Techniques ................................. 13
Ocimum Biosolutions Ltd. (India) .................................... 45 Bruker Acquires Nucleic Acid Testing (NAT) Assays and
1.1.2.3.1 Allele-Specific PCR..................................... 13 Syndromic Panel Technology .......................................... 68
Qiagen N.V. (The Netherlands) ....................................... 46
1.1.2.3.2 Assembly PCR or Polymerase Cycling Thermo Fisher Scientific, Inc. (United States).................. 49 BD MAX Vaginal and CT/GC/TV Panels receives FDA
Assembly (PCA) ........................................................ 13 approval ......................................................................... 68
1.1.2.3.3 Asymmetric PCR........................................ 13 4. KEY BUSINESS TRENDS ...................................... 51 Biocartis receives 1.4 M grant from VLAIO .................. 68
1.1.2.3.4 Helicase-Dependent Amplification ........... 13 Thermo Fishers DNA Detection Kit Receives FBI approvals LabCorp launches cobras 8800 system from Roche ........ 69
to Identify male-specific Y chromosome markers ........... 51 RainDance Technologies Showcases its Picodroplet
1.1.2.3.5 Hot Start PCR ............................................ 13
Genomic Health and Biocartis Enter into Agreement to Platform at ASHG 2016 ................................................... 69
1.1.2.3.6 Intersequence-Specific PCR (ISSR) ............ 14 Develop Oncotype DX Breast Recurrence Score Test ...... 51 Droplet Digital Technology Presented at ASHG 2016 ... 69
1.1.2.3.7 Inverse PCR ............................................... 14 Bio-Rad Unveils RT-PCR Assay Kit for Simultaneous Thermo Fisher scientific Launches NGM Detect Kit ........ 69
1.1.2.3.8 Ligation-Mediated PCR ............................. 14 Detection of Zika, Dengue, and Chikungunya Viruses ..... 52 Bioline accredited to the ISO 13485 Quality Standard .... 70
1.1.2.3.9 Methylation-Specific PCR (MSP) ............... 14 Angle Plc Enters into Marketing Partnership with QIAGEN .... 52 Bioline Expands the SensiFAST family of real-time PCR
1.1.2.3.10 Miniprimer PCR ....................................... 14 QIAGEN and Clinical Genomics Join Forces to work on products ......................................................................... 70
1.1.2.3.11 Multiplex Ligation-Dependent Probe Colorectal Cancer ............................................................ 52 Thermo Fisher Scientific Partners with Hamilton Bonaduz
FDA Approval for Thermo Fishers TaqPath Zika Virus Kit 53 AG .................................................................................. 70
Amplification (MLPA) ............................................... 14
Bioline Expands JetSeq portfolio .................................. 53 Maxwell RSC PureFood GMO and Authentication Kit from
1.1.2.3.12 Multiplex PCR.......................................... 14 Thermo Fisher Completes CE-IVD Registration of its Promega ......................................................................... 70
1.1.2.3.13 Nested PCR ............................................. 15 QuantStudio 5 Dx System for In Vitro Diagnostic Use in Bio-Rad Introduces an Assay website to identify or design
1.1.2.3.14 Overlap-Extension PCR or Splicing by Europe ............................................................................ 53 Droplet Digital PCR Assays ........................................... 71
Overlap Extension (SOE) .......................................... 15 Fluidigm and Ascendas Genomics Partner to Develop Roche receives FDA, CLIA waiver for cobas Influenza A/B
1.1.2.3.15 Reverse Transcription PCR (RT-PCR) ....... 15 Microfluidic Molecular Diagnostics in China ................... 54 & RSV test....................................................................... 71
1.1.2.3.16 Solid Phase PCR....................................... 15 Agilent Technologies Launches AriaDx Real-Time PCR Renewal of Thermo Fisher Scientific and DuPont Nutrition
1.1.2.3.17 Thermal Asymmetric Interlaced PCR (TAIL-PCR) . 15 System in Europe ............................................................ 54 & Health's Deal to Supply BAX System Q7 Platform ....... 71
Fluidigm Unveils Advanta Immuno-Oncology Gene Release of Bio-Rad's New ddPCR CHO and ddPCR E. coli
1.1.2.3.18 Touchdown PCR (Step-Down PCR) .......... 15
Expression PCR Assay ...................................................... 54 Residual DNA Quantification Kits .................................... 71
1.1.3 Applications of PCR ......................................... 16 Formulatrix, Inc Introduces CONSTELLATION Digital PCR Bio-Rad's Droplet Digital PCR-Based Assay for Rapid and
1.1.3.1 Virology........................................................ 16 System ............................................................................ 55 Cost-Effective Quantification of Genome-Editing Events 72
1.1.3.2 Mycology and Parasitology .......................... 16 Roche Introduces Cobas MRSA/SA Nucleic Acid Test ...... 55 BD Collaborated with Check-Points to Develop and Supply
1.1.3.3 Microbiology ................................................ 17 Bio-Rad Launches First Droplet Digital PCRBased Assays .. 55 BD MAX Assays for CRO Detection............................... 72
1.1.3.3.1 Bacteriology .............................................. 18 Bio-Rad Unveils CFX Maestro Software for PCR Data Seegene to Launch Universal SG Fluorescence Oligo
1.1.3.4 Dentistry ...................................................... 18 Analysis ........................................................................... 56 System ............................................................................ 72
FDA Approval for QIAGENs Artus CMV QS-RGQ MDx Kit Release of Bioline's New MyTaq Plant-PCR Kit ............. 72
1.1.3.5 Agricultural Biotechnology........................... 19
for CMV Testing .............................................................. 56 US FDA Granted Emergency Use Authorization for Idylla
1.1.3.6 Other Select Applications............................. 19 Roche Receives FDA Approval for CMV Viral Load Testing Ebola Virus Triage Test ................................................... 73
2. KEY MARKET TRENDS ........................................ 21 on Cobas 6800/8800 Systems ....................................... 57 First Prospective Clinical Trial of Liquid Biopsy Using ddPCR
2.1 Expediting the PCR Process Now Possible .......... 21 FDA 510(K) Clearance for BDCs Molecular Test for Validated the Use of cfDNA as a Predictive Diagnostic Tool ... 73
2.2 Emergence of Ultrafast Real Time Q-Plasmonic PCR .. 22 Harmful Intestinal Bacteria Causing Infectious Diarrhea . 57 Thermo Scientific SureTect Real-Time PCR Assays for
2.3 Contemporary Research Using BNA-Based Digital PCR.. 22 Sysmex to Acquire Oxford Gene Technology................... 58 Precise Detection of Molecular Pathogens ..................... 74
Seegene Enters the U.S. Diagnostic Market in Five New ddPCR Multiplex Mutation Screening Kits
Bridged Nucleic Acids (BNA) Technology ................. 23
Collaboration with Thermo Fisher ................................... 58 Launched by Bio-Rad ...................................................... 74
2.4 Detection of Early-Stage Liver Cancer Improves by Seegene Develops Second-Generation real-time PCR New Thermo Scientific SureTect Cronobacter Species Real-
Using CTC-iChip with Digital PCR Assay.................... 24 technology Universal SG Fluorescence-labeled oligo ...... 58 Time PCR Assay to Aid Infant Formula Producers ........... 74
2.5 Propidium Monoazide-PCR Assay Developed for Bruker to Release new Clinical Microbiology kits and US FDA Approved cobas Zika test to Screen Blood
Detecting viable Lactobacillus brevis in Beer ........... 24 Assays at ECCMID ........................................................... 59 Samples on the cobas 6800/8800 Systems ................... 75

Click here to buy the report


Page 3
Polymerase Chain Reaction (PCR) A Global Market Overview
October 2017 |344 Pages | 216 Charts | Price $4860

COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, the Bio-Rad Laboratories launches PrimePCR Assays for Real- Complete Genomics, Inc. (United States) ..................... 153
First Quantitative HCV RNA Test to Receive FDA Approval Time PCR ......................................................................... 86 Danaher Corporation (United States) ........................... 154
for Use as an Aid to Diagnose an Active HCV Infection ... 75 SciLifeLab sets up Swedish national center for single-cell Beckman Coulter, Inc. (United States) .......................... 155
New Three-Color Crystal Digital PCR System Launched by biology ............................................................................ 86 Fluidigm Corporation (United States) ........................... 156
Stilla Technologies .......................................................... 75 Roche MRSA/SA Test receives FDA clearance ................. 86 Formulatrix, Inc. (United States) ................................... 157
Unveiling of Bioline's EPIK miRNA Select Kits ............... 75 Qiagen secures additional EGFR pathway-related Illumina Inc. (United States) ......................................... 158
CE IVD Marking for Bio-Rad's QX200 Droplet Digital PCR System.....76 intellectual property licenses from Roche ....................... 86 Epicentre (United States)............................................ 159
Thermo Scientific SureTect Escherichia coli O157:H7 PCR Assay Life Science Industry awards for Bio-Rad Protein Promega Corporation (United States) .......................... 160
Granted NF Validation Certificate by AFNOR Certification ..... 76 Expression Products, Genomic Workflow Solutions ........ 87 Roche Diagnostics Corporation (United States) ............ 161
GE Healthcare to Set Up Headquarters in Chicago ......... 76 Bio-Rad launches ddPCR KRAS Screening Multiplex Kit ... 87 Sigma-Aldrich (United States) ....................................... 161
Milestone Reached by Qiagen with its Portfolio of Master cobas TaqScreen MPX Test, v2.0 Receives FDA Approval .... 87 Thermo Fisher Scientific, Inc. (United States) ............... 162
Collaboration Agreements with Major Pharmaceutical
Companies to Develop Companion Diagnostics.............. 76 5. GLOBAL MARKET OVERVIEW ............................. 88 1.6 Country-wise Analysis of North American
Biocartis Joined Forces with Merck to Develop and 5.1 Global Polymerase Chain Reaction Market Polymerase Chain Reaction Market ....................... 164
Commercialize a New Liquid Biopsy RAS Biomarker Test Overview by Product Segment ................................ 89 1.6.1 The United States ....................................... 164
for mCRC Patients .......................................................... 77 5.1.1 Polymerase Chain Reaction Product Segment 1.6.1.1 United States Polymerase Chain Reaction
US FDA Approved Roche's cobas HIV-1 Viral Load Test for Market Overview by Global Region ......................... 91 Market Overview by Product Segment .................. 165
Use on the cobas 6800/8800 Systems .......................... 77
5.1.1.1 Instruments ................................................. 91 1.6.1.2 United States Polymerase Chain Reaction
JetSeq DNA Library Preparation Kit, the First Product in a
New Line of Kits from Bioline for NGS Sample Preparation ... 77 5.1.1.2 Reagents & Consumables ............................ 93 Market Overview by Application Area ................... 167
Roche Finalized the Acquisition of Kapa Biosystems....... 78 5.1.1.3 Software & Services ..................................... 95 1.6.1.3 United States Polymerase Chain Reaction
RainDance to Develop Ultra-Sensitive, Highly Precise and 5.2 Global Polymerase Chain Reaction Market Market Overview by End-Use Sector ..................... 169
Low Cost NGS and Digital PCR Methods in Collaboration Overview by Application Area ................................. 97
1.6.2 Canada ....................................................... 171
with BSRI ........................................................................ 78 5.2.1 Polymerase Chain Reaction Application Area
Sigma-Aldrich Acquired by Merck ................................... 78 1.6.2.1 Canadian Polymerase Chain Reaction Market
Market Overview by Global Region ......................... 99 Overview by Product Segment .............................. 172
Addition of HIV-1, HCV and HCV GT Assays Broaden
5.2.1.1 Clinical Diagnostics ...................................... 99 1.6.2.2 Canadian Polymerase Chain Reaction Market
Roche's Available Menu on the cobas 4800 System ....... 79
Roche's cobas HBV and cobas HCV viral load tests, the 5.2.1.2 Life Sciences ............................................... 101 Overview by Application Area ............................... 174
first assays with US FDA Approval for use on the cobas 5.2.1.3 Other Applications ..................................... 103
1.6.2.3 Canadian Polymerase Chain Reaction Market
6800 and cobas 8800 Systems ...................................... 79 5.3 Global Polymerase Chain Reaction Market Overview by End-Use Sector.................................. 176
RIVM Selected Roche to Implement the cobas HPV Test Overview by End-Use Sector.................................. 105
as the First-Line, Primary Screening Test in the National 5.3.1 Polymerase Chain Reaction End-Use Sector 1.6.3 Mexico ....................................................... 178
Cervical Cancer Screening Program ................................ 79 Market Overview by Global Region ....................... 107 1.6.3.1 Mexican Polymerase Chain Reaction Market
Release of Bio-Rad's One-Step RT-ddPCR Advanced Kit for Overview by Product Segment .............................. 179
5.3.1.1 Academic & Research Institutes ................ 107
Probes ............................................................................ 79 1.6.3.2 Mexican Polymerase Chain Reaction Market
Launch of Roche's First Oncology Assay Using Either 5.3.1.2 Clinical Diagnostics Labs & Hospitals ......... 109
5.3.1.3 Pharmaceutical & Biotechnology Sectors .. 111 Overview by Application Area ............................... 181
Plasma or Tumour Tissue Samples ................................. 80
FDA CLIA Waiver Granted for Roche's cobas Influenza 5.3.1.4 Other End-Use Sectors ............................... 113 1.6.3.3 Mexican Polymerase Chain Reaction Market
A/B Test for Use on the cobas Liat System ................... 80 Overview by End-Use Sector.................................. 183
Seegene Joined Forces with BD for the Development of PART B: REGIONAL MARKET PERSPECTIVE ..115
2. EUROPE .......................................................... 185
Multiplex Real-Time PCR Reagents for the BD MAX System80 REGIONAL MARKET OVERVIEW ........................... 117
Release of Bioline's New EPIK miRNA Panel Assays ..... 80 2.1 European Polymerase Chain Reaction Market
MHTP's Medical Genomics Facility to House Australia's 1. NORTH AMERICA ............................................ 117 Overview by Geographic Region ............................ 186
First Single-Cell Genomics Centre of Excellence ............. 81 1.1 North American Polymerase Chain Reaction 2.2 European Polymerase Chain Reaction Market
FDA Approved Qiagen's therascreen EGFR Test as a Market Overview by Geographic Region ............... 118 Overview by Product Segment .............................. 188
Companion Diagnostic for Guiding the Use of 1.2 North American Polymerase Chain Reaction 2.2.1 Polymerase Chain Reaction Product Segment
AstraZeneca's IRESSA in Treating NSCLC Patients ......... 81 Market Overview by Product Segment .................. 120 Market Overview by European Region .................. 190
MDRO Tests Developed by Fluidigm in Collaboration with OpGen.....81
1.2.1 Polymerase Chain Reaction Product Segment 2.2.1.1 Instruments ............................................... 190
Seegene to Develop Multiplex assay panels menu for
Qiagen's QIAsymphony RGA MDx Automation Platform 81
Market Overview by NA Region ............................. 122 2.2.1.2 Reagents & Consumables .......................... 192
Hitachi High-Technologies Collaborated with Qiagen to Develop 1.2.1.1 Instruments ............................................... 122 2.2.1.3 Software & Services ................................... 194
New Automation Systems Based on PCR and NGS Technologies .. 82 1.2.1.2 Reagents & Consumables .......................... 124 2.3 European Polymerase Chain Reaction Market
CE Marking Obtained by Beckman Coulter's DxN VERIS 1.2.1.3 Software & Services ................................... 126 Overview by Application Area ............................... 196
HCV Assay and DxN VERIS HIV-1 Assay ........................... 82 1.3 North American Polymerase Chain Reaction 2.3.1 Polymerase Chain Reaction Application Area
510(k) Clearance Received by Roche's cobas Cdiff Test .. 82
Market Overview by Application Area ................... 128 Market Overview by European Region .................. 198
510(k) Clearance Received by Roche's cobas HSV 1 and 2 Test . 82
Biocartis Collaborated with Fast-track Diagnostics to 1.3.1 Polymerase Chain Reaction Application Area 2.3.1.1 Clinical Diagnostics .................................... 198
Develop a Range of Multiplex Infectious Disease Tests on Market Overview by NA Region ............................. 130 2.3.1.2 Life Sciences............................................... 200
its Idylla System ........................................................... 83 1.3.1.1 Clinical Diagnostics .................................... 130 2.3.1.3 Other Applications ..................................... 202
Seegene's Allplex Gastrointestinal Full Panel Assay 1.3.1.2 Life Sciences ............................................... 132 2.4 European Polymerase Chain Reaction Market
Received CE-IVD Mark .................................................... 83 1.3.1.3 Other Applications ..................................... 134 Overview by End-Use Sector.................................. 204
US FDA Granted CLIA Waiver for Roche's cobas Strep A 1.4 North American Polymerase Chain Reaction 2.4.1 Polymerase Chain Reaction End-Use Sector
Test for Use on the cobas Liat System .......................... 83
Market Overview by End-Use Sector ..................... 136 Market Overview by European Region .................. 206
Roche's cobas KRAS Mutation Test Received FDA
Approval for Diagnostic Use ........................................... 83
1.4.1 Polymerase Chain Reaction End-Use Sector 2.4.1.1 Academic & Research Institutes ................ 206
DxN VERIS Molecular Diagnostics System Presented by Market Overview by NA Region ............................. 138 2.4.1.2 Clinical Diagnostics Labs & Hospitals ......... 208
Beckman Coulter at ECCMID in Denmark ....................... 84 1.4.1.1 Academic & Research Institutes ................ 138 2.4.1.3 Pharmaceutical & Biotechnology Sectors .. 210
RainDance Form Distribution Pacts to Meet the Increasing 1.4.1.2 Clinical Diagnostics Labs & Hospitals ......... 140 2.4.1.4 Other End-Use Sectors ............................... 212
Demand for Liquid Biopsy Applications outside the US .. 84 1.4.1.3 Pharmaceutical & Biotechnology Sectors .. 142 2.5 Major Market Players ...................................... 214
An Integrated Multiplex Real-time PCR Assay for 1.4.1.4 Other End-Use Sectors ............................... 144 Biocartis Nv (Belgium) .................................................. 214
Bloodstream Infections Developed by Biocartis in 1.5 Major Market Players ...................................... 146 Bioline Reagents Limited (United Kingdom) ................. 215
Collaboration with Microbiome ...................................... 84 Abbott Laboratories (United States) ............................. 146 Dnavision Sa (Belgium) ................................................. 216
BD MAX CT/GC/TV and CT/GC Assays Received CE Mark ... 85 Abbott Molecular Inc. (United States) ........................... 147 Eppendorf Ag (Germany) .............................................. 217
Promega releases the PowerQuant System ................. 85 Agilent Technologies, Inc. (United States) ..................... 148 Exiqon A/S (Denmark) .................................................. 218
Commercial availability of Roches cobas DPX test for Becton, Dickinson And Company (United States) .......... 150 F. Hoffmann-La Roche Ltd (Switzerland) ....................... 219
parvovirus B19 (B19V) and hepatitis A virus (HAV) ......... 85 Bd Biosciences, Systems and Reagents Inc. (United States) . 150 Ge Healthcare Life Sciences (United Kingdom) ............. 220
Roche launches cobas HBV assay and receives CE mark 85 Bio-Rad Laboratories, Inc. (United States)..................... 151 Merck KGaA (Germany) ................................................ 221
Bio-Rad launches new PrimePCR Droplet Digital PCR Raindance Technologies, Inc. (United States) ............... 152 Qiagen N.V. (The Netherlands) ..................................... 222
(ddPCR) Assays ............................................................ 85 Bruker Corporation (United States)............................... 153 Stilla Technologies (France) .......................................... 225

Click here to buy the report


Page 4
Polymerase Chain Reaction (PCR) A Global Market Overview
October 2017 |344 Pages | 216 Charts | Price $4860

2.6 Country-wise Analysis of European Polymerase 3.2 Asia-Pacific Polymerase Chain Reaction Market 3.6.3 Japan ......................................................... 307
Chain Reaction Market .......................................... 226 Overview by Product Segment .............................. 264 3.6.3.1 Japanese Polymerase Chain Reaction Market
2.6.1 France ........................................................ 226 3.2.1 Polymerase Chain Reaction Product Segment Overview by Product Segment .............................. 308
2.6.1.1 French Polymerase Chain Reaction Market Market Overview by Asia-Pacific Region................ 266 3.6.3.2 Japanese Polymerase Chain Reaction Market
Overview by Product Segment .............................. 227 3.2.1.1 Instruments ............................................... 266 Overview by Application Area ............................... 310
2.6.1.2 French Polymerase Chain Reaction Market 3.2.1.2 Reagents & Consumables .......................... 268 3.6.3.3 Japanese Polymerase Chain Reaction Market
Overview by Application Area................................ 229 3.2.1.3 Software & Services ................................... 270 Overview by End-Use Sector.................................. 312
2.6.1.3 French Polymerase Chain Reaction Market 3.3 Asia-Pacific Polymerase Chain Reaction Market 3.6.4 South Korea ............................................... 314
Overview by End-Use Sector .................................. 231 Overview by Application Area ............................... 272 3.6.4.1 South Korean Polymerase Chain Reaction
3.3.1 Polymerase Chain Reaction Application Area Market Overview by Product Segment .................. 315
2.6.2 Germany .................................................... 233
Market Overview by Asia-Pacific Region................ 274 3.6.4.2 South Korean Polymerase Chain Reaction
2.6.2.1 German Polymerase Chain Reaction Market
3.3.1.1 Clinical Diagnostics .................................... 274 Market Overview by Application Area ................... 317
Overview by Product Segment .............................. 234
3.3.1.2 Life Sciences ............................................... 276 3.6.4.3 South Korean Polymerase Chain Reaction
2.6.2.2 German Polymerase Chain Reaction Market
3.3.1.3 Other Applications ..................................... 278 Market Overview by End-Use Sector ..................... 319
Overview by Application Area................................ 236
3.4 Asia-Pacific Polymerase Chain Reaction Market
2.6.2.3 German Polymerase Chain Reaction Market 3.6.5 Rest of Asia-Pacific ..................................... 321
Overview by End-Use Sector.................................. 280
Overview by End-Use Sector .................................. 238 3.6.5.1 Rest of Asia-Pacific Polymerase Chain Reaction
3.4.1 Polymerase Chain Reaction End-Use Sector
2.6.3 Italy ........................................................... 240 Market Overview by Asia-Pacific Region................ 282 Market Overview by Product Segment .................. 322
2.6.3.1 Italian Polymerase Chain Reaction Market 3.4.1.1 Academic & Research Institutes ................ 282 3.6.5.2 Rest of Asia-Pacific Polymerase Chain Reaction
Overview by Product Segment .............................. 241 3.4.1.2 Clinical Diagnostics Labs & Hospitals ......... 284 Market Overview by Application Area ................... 324
2.6.3.2 Italian Polymerase Chain Reaction Market 3.4.1.3 Pharmaceutical & Biotechnology Sectors .. 286 3.6.5.3 Rest of Asia-Pacific Polymerase Chain Reaction
Overview by Application Area................................ 243 3.4.1.4 Other End-Use Sectors ............................... 288 Market Overview by End-Use Sector ..................... 326
2.6.3.3 Italian Polymerase Chain Reaction Market 3.5 Major Market Players ...................................... 290 4. REST OF WORLD .............................................. 328
Overview by End-Use Sector .................................. 245 Hokkaido System Science Co., Ltd. (Japan) .................... 290 4.1 Rest of World Polymerase Chain Reaction Market
2.6.4 The United Kingdom .................................. 247 Ocimum Biosolutions Ltd. (India) .................................. 291 Overview by Product Segment .............................. 329
Shimadzu Corporation (Japan) ...................................... 292
2.6.4.1 United Kingdom Polymerase Chain Reaction 4.2 Rest of World Polymerase Chain Reaction Market
Market Overview by Product Segment .................. 248 3.6 Country-wise Analysis of Asia-Pacific Polymerase Overview by Application Area ............................... 331
2.6.4.2 United Kingdom Polymerase Chain Reaction Chain Reaction Market .......................................... 293 4.3 Rest of World Polymerase Chain Reaction Market
Market Overview by Application Area ................... 250 3.6.1 China ......................................................... 293 Overview by End-Use Sector.................................. 333
2.6.4.3 United Kingdom Polymerase Chain Reaction 3.6.1.1 Chinese Polymerase Chain Reaction Market Hy Laboratories Ltd (Hylabs) (Israel) A Major Market
Market Overview by End-Use Sector ..................... 252 Overview by Product Segment .............................. 294 Player ........................................................................... 335
3.6.1.2 Chinese Polymerase Chain Reaction Market
2.6.5 Rest of Europe ........................................... 254 Overview by Application Area ............................... 296
PART C: GUIDE TO THE INDUSTRY............... 336
2.6.5.1 Rest of Europe Polymerase Chain Reaction 1. NORTH AMERICA ............................................... 336
3.6.1.3 Chinese Polymerase Chain Reaction Market
Market Overview by Product Segment .................. 255 2. EUROPE.............................................................. 340
Overview by End-Use Sector.................................. 298
2.6.5.2 Rest of Europe Polymerase Chain Reaction 3. ASIA-PACIFIC ...................................................... 341
Market Overview by Application Area ................... 257 3.6.2 India .......................................................... 300 4. REST OF WORLD ................................................ 342
2.6.5.3 Rest of Europe Polymerase Chain Reaction 3.6.2.1 Indian Polymerase Chain Reaction Market
Market Overview by End-Use Sector ..................... 259 Overview by Product Segment .............................. 301 PART D: ANNEXURE ....................................343
3.6.2.2 Indian Polymerase Chain Reaction Market 1. RESEARCH METHODOLOGY ............................... 343
3. ASIA-PACIFIC................................................... 261 Overview by Application Area ............................... 303 2. FEEDBACK .......................................................... 345
3.1 Asia-Pacific Polymerase Chain Reaction Market 3.6.2.3 Indian Polymerase Chain Reaction Market
Overview by Geographic Region ............................ 262 Overview by End-Use Sector.................................. 305

About Industry Experts


Industry Experts market research, backed by years of experience and an
analytical team dedicated to providing the most optimal business
solutions, has been specifically designed to provide a variety of benefits,
both current and future. Our leading-edge publications make the life easy
for corporate strategists, investors, analysts and researchers, startups,
consultants, financial and banking executives, academicians and many
more. The company also provides customized research reports to cater
the needs of the industry.
INDUSTRY EXPERTS
Business intelligence provides the critical link between comprehending
prevailing market conditions and devising strategies to maximize 1-7-19/C, Street No. 8, Habsiguda
parameters, such as revenues, profits and return on investment in order to Hyderabad 500007, India
gain market share. The significance of market research can be largely
Phone: +91-40-4018-1314
understood through the range of factors that impact businesses. These can
comprise market size (current and projected), geographic market reach and Fax: +91-40-4027-2381
demand and supply scenario, to name a few. Our ongoing quest to collect
up to date and accurate information by conducting online surveys, personal info@industry-experts.com
interviews, taking the opinions of senior level executives will enable us to
serve our clients better in every possible aspect. industry-experts.com
More about Industry Experts

Click here to buy the report


Page 5